Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.

Urology - 1 Jan 2015

Kader A Karim, Liss Michael A, Trottier Greg, Kim Seong-Tae, Sun Jielin, Zheng S Lilly, Chadwick Karen, Lockwood Gina, Xu Jianfeng, Fleshner Neil E

Abstract excerpt

OBJECTIVE: To determine to what extent prostate cancer (PCa) risk prediction is improved by adding prostate-specific antigen (PSA) to a baseline model including genetic risk. METHODS: Peripheral blood deoxyribonucleic acid was obtained from Caucasian men undergoing prostate biopsy at the University of Toronto (September 1, 2008 to January 31, 2010). Thirty-three PCa risk-associated single nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Genetic Predisposition to Disease

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Risk Assessment

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 25530379
DOI: 10.1016/j.urology.2014.07.081
PMCID: PMC5398897

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.PMID 25530379Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study.Semantic proximity Read ↗

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Semantic proximity Read ↗

Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.Semantic proximity Read ↗

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.Semantic proximity Read ↗

Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.Semantic proximity Read ↗

Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Semantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.Semantic proximity Read ↗

Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.Semantic proximity Read ↗

Personalized prostate cancer screening: improving PSA tests with genomic information.Semantic proximity Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.